Pediatric Ischemic Stroke Tied to Attention-Deficit/Hyperactivity Disorder Risk
Researchers sought to assess the risk for attention-deficit/hyperactivity disorder in children after pediatric ischemic stroke.
Researchers sought to assess the risk for attention-deficit/hyperactivity disorder in children after pediatric ischemic stroke.
The approval was based on data from a phase 3 trial that assessed Qelbree in adults 18 to 65 years of age with ADHD.
A significant mental health gap exists between adults with and without attention-deficit hyperactivity disorder (ADHD).
A team of investigators sought to evaluate whether growth hormone levels and thyroid function were different in children with ADHD compared with those without ADHD.
Prenatal opioid exposure is associated with a significantly higher risk for subsequent attention-deficit/hyperactivity disorder (ADHD) and carries a higher risk than exposure to other substances.
For the most part, research on the EEG signatures of ADHD has concentrated on its frequency spectrum or event related evoked potentials. In this study, researchers investigated EEG microstates.
A population-based cohort study in the US examined the data from over 2 million Medicaid patients to ascertain if there were any differences in the incidence and timing for diagnosis of neurodevelopmental disorders in publicly vs privately insured children.
The risk for mortality is increased significantly for persons with autism spectrum disorders (ASD) and those with attention-deficit/hyperactivity disorder (ADHD).
Authors analyzed the documentation of primary care professionals from electronic health records (EHRs) to find out the rate of PTBM recommendation for 4-5 year old patients with an ADHD diagnosis, ADHD symptoms or who were prescribed ADHD medication.
In a recent survey, more than half the college students with ADHD had at least 1 psychiatric disorder. The recent WHO World Mental Health Survey of college students assessed comorbidities in more than 15,000 college freshmen across 9 countries.